Claim Adjudication, Where Accuracy Meets Margin
Claim adjudication sits at the intersection of money, complexity, and risk.
Small inconsistencies across policies, contracts, and workflows make the process increasingly complex. At the same time, decisions made at speed can erode margin or lack the transparency and documentation required when questions arise—whether from auditors, regulators, or internal finance teams.
iCAS brings consistency, transparency, and expert governance to claim adjudication—helping health plans prevent silent financial leakage without sacrificing control.
See how iCAS works
Protect margins with predictable, defensible claims spend.
Reduce rework while scaling consistent adjudication decisions.
Ensure audit-ready decisions with clear governance and accountability
$44M
Original Payment
$38M
Payment After Using iCAS
$6M
Savings with iCAS
14%
Savings for IPA
Claims Intelligence, Governed by Experts
iCAS brings consistency and transparency to claim adjudication by combining intelligence at scale with expert governance.
AI continuously analyzes claims and payment behavior to surface variance, inconsistency, and financial risk—highlighting where attention matters most. Experts then review, contextualize, and strengthen those recommendations before they are shared for action.
The result is smarter, more consistent claim adjudication—without surrendering control or accountability.
Built for Scrutiny, Beyond Check-the-Box Compliance
Healthcare oversight evolves. Questions come later.
iCAS isn’t tied to a specific regulatory moment because decisions aren’t automated or opaque. They are AI-informed and expert-approved, with clear rationale and ownership built into the workflow.
Whether the focus is financial accuracy, operational consistency, or external review, claim decisions remain explainable, traceable, and defensible—by design.
Impact that Shows Up on the P&L
Organizations using iCAS see measurable financial impact:
Not through brute-force reviews or added friction—but by directing expert attention to the decisions that matter most.
The investigation has triggered bipartisan concern, with lawmakers scrutinizing whether risk adjustment practices have crossed ethical lines. The move signals a shift from passive oversight to active enforcement, putting the future of MA funding and the industry's credibility at a tipping point.
Continue Reading ›
The investigation has triggered bipartisan concern, with lawmakers scrutinizing whether risk adjustment practices have crossed ethical lines. The move signals a shift from passive oversight to active enforcement, putting the future of MA funding and the industry's credibility at a tipping point.
Continue Reading ›
The investigation has triggered bipartisan concern, with lawmakers scrutinizing whether risk adjustment practices have crossed ethical lines. The move signals a shift from passive oversight to active enforcement, putting the future of MA funding and the industry's credibility at a tipping point.
Continue Reading ›